Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Avoiding Drug Resistance by Substrate Envelope-Guided Design: Toward Potent and Robust HCV NS3/4A Protease Inhibitors

Class:IdLiteratureReference:9732406
_displayNameAvoiding Drug Resistance by Substrate Envelope-Guided Design: Toward Potent and Robust HCV NS3/4A Protease Inhibitors
_timestamp2021-05-27 01:36:11
author[Person:9732221] Matthew, Ashley N
[Person:9732260] Zephyr, Jacqueto
[Person:9732348] Nageswara Rao, Desaboini
[Person:9732385] Henes, Mina
[Person:9732289] Kamran, Wasih
[Person:9732276] Kosovrasti, Klajdi
[Person:9732361] Hedger, Adam K
[Person:9732305] Lockbaum, Gordon J
[Person:9732338] Timm, Jennifer
[Person:9684425] Ali, Akbar
[Person:9732271] Kurt Yilmaz, Nese
[Person:9684435] Schiffer, Celia A
created[InstanceEdit:9732255] Shamovsky, Veronica, 2021-05-27
journalmBio
pubMedIdentifier32234812
titleAvoiding Drug Resistance by Substrate Envelope-Guided Design: Toward Potent and Robust HCV NS3/4A Protease Inhibitors
volume11
year2020
(literatureReference)[Summation:9732409] Hepatitis C virus (HCV) encodes a polyprotein, which is prot...
[Change default viewing format]
No pathways have been reviewed or authored by Avoiding Drug Resistance by Substrate Envelope-Guided Design: Toward Potent and Robust HCV NS3/4A Protease Inhibitors (9732406)